Interventions for valvular disease First use of 3D-TEE model-based fully automatic fusion of 3D-MSCT and fluoroscopy during transcatheter aortic valve implantation Brouwer J, Gheorghe L, Rensing B, Swaans M November 15, 2019 | 10.4244/EIJ-D-19-00261
Thrombi outside the left atrial appendage: “small potatoes”? Maarse M, Boersma L, Swaans M June 12, 2019 | 10.4244/EIJV15I3A39
Interventions for valvular disease First use of 3D-TEE Model based Fully Automatic Fusion of 3D-MSCT and Fluoroscopy during Transcatheter Aortic Valve Implantation Brouwer J, Gheorghe L, Rensing B, Swaans M May 7, 2019 | 10.4244/EIJ-D-19-00261
Interventions for valvular disease Impact of mitral valve treatment choice on mortality according to aetiology Kortlandt F, Velu J, Schurer R, Van den Branden B, Bouma B, Kelder J, Eefting F, Swaans M, Rensing B, Baan Jr J, Van der Heyden J April 16, 2019 | 10.4244/EIJ-D-18-00874
Hybrid transcatheter left ventricular reconstruction for the treatment of ischaemic cardiomyopathy Zivelonghi C, Klein P, Swaans M, Agostoni P March 20, 2018 | 10.4244/EIJ-D-17-00413
How to plan an overlap-free projection on CTA or fluoroscopy to facilitate quantitative analysis of aortic regurgitation Teng J, Nijenhuis V, Swaans M, Yong G, Schultz C February 20, 2018 | 10.4244/EIJ-D-17-00080
Interventions for valvular disease Complete blood flow obstruction due to a distally embolised Edwards SAPIEN valve prosthesis Nijenhuis V, Swaans M, ten Berg J December 9, 2016 | 10.4244/EIJ-D-16-00064
Interventions for heart failure Microprobe transoesophageal echocardiographic guidance during transcatheter interatrial septal device implantation in heart failure with a preserved ejection fraction Snijder R, Swaans M, Van der Heyden J, Post M June 20, 2016 | 10.4244/EIJV12I3A65
Unintentional sealing of the mitral valve with a second MitraClip. “Once bitten, twice shy” Alipour A, Swaans M, Post M, Rensing B, Eefting F, Van der Heyden J September 22, 2015 | 10.4244/EIJV11I5A115
An objective and reproducible method for quantification of aortic regurgitation after TAVI Schultz C, Slots T, Yong G, Aben J-P, Van Mieghem N, Swaans M, Rahhab Z, Faquir N, van Geuns R, Mast G, Zijlstra F, de Jaegere P July 21, 2014 | 10.4244/EIJY14M05_06
New issue Antiplatelet strategies for complex PCI, are all DES equal at 10-year follow-up? cost-effectiveness of TAVR…find all the answers in the new issue (Intravascular lithotripsy (3.5 mm Shockwave; left), followed by balloon dilatation (4.0 mm NC; right)) December 6, 2019
Trials Book New update! Discover 17 new trials (The Trials book is supported by Biotronik) October 29, 2019
Editorial 2019 – A leap year for valvular heart disease (Course directors PCR London Valves 2019) November 15, 2019